May Guo

CEO Novaribo

Seminars

Tuesday 21st July 2026
Innovation in Enzymes & Assays for mRNA Manufacturing
11:30 am
  • Engineering T7 RNAP to improve IVT performance and address key mRNA manufacturing challenges
  • Developing T7 RNAP mutants to reduce dsRNA impurity, lower cap analog usage, and improve RNA integrity for long mRNA sequences
  • Building high-yield IVT systems and reliable dsRNA quantification methods to support mRNA process development and QC
May Guo - 6th mRNA-Based Therapeutics Summit Speaker